July
Exempt Chemical Preparations Under the Controlled Substances Act (PDF) (July 1, 2025)
June
Notice of Intent: Temporary Placement of Seven Benzimidazole-Opioids in Schedule I (PDF) (June 26, 2025)
Scott Hansen, A.R.N.P.; Default Decision and Order (PDF) (June 26, 2025)
Bohdan Olesnicky, M.D.; Decision and Order (PDF) (June 26, 2025)
Arizona Department of Corrections (PDF) (June 24, 2025)
William Thompson IV, M.D.; Decision and Order (PDF) (June 23, 2025)
New Scam Letters and Calls Target Medical Practitioners (PDF) (June 23, 2025)
AndersonBrecon, Inc. DBA PCI Pharma Services (PDF) (June 18, 2025)
Veranova, L.P. (PDF) (June 18, 2025)
Veranova, L.P. (PDF) (June 18, 2025)
AJNA Biosciences (PDF) (June 18, 2025)
American Radiolabeled Chem (PDF) (June 18, 2025)
James F. Brown, D.P.M.; Default Decision and Order (PDF) (June 13, 2025)
Proposed Rule: Placement of Three Specific Fentanyl-Related Substances in Schedule I (PDF) (June 10, 2025)
Proposed Rule: Placement of 3-Methoxyphencyclidine (1-[1-(3-methoxyphenyl) cyclohexyl]piperidine) in Schedule I (PDF) (June 10, 2025)
Harry Kram, M.D.; Decision and Order (PDF) (June 10, 2025)
Serge Menkin, M.D.; Decision and Order (PDF) (June 10, 2025)
Ron Dunchok, M.D.; Decision and Order (PDF) (June 9, 2025)
Lee S. Altman, M.D.; Decision and Order (PDF) (June 5, 2025)
Usona Institute, Inc. (PDF) (June 5, 2025)
ANI Pharmaceuticals Inc. (PDF) (June 5, 2025)
Proposed Rule: Designation of Propionyl Chloride as a List I Chemical (PDF) (June 3, 2025)
Proposed Rule: Placement of 4-Fluoroamphetamine in Schedule I (PDF) (June 3, 2025)
Correction: Placement of 2-Methyl AP-237 in Schedule I (PDF) (June 3, 2025)
Veranova, L.P. (PDF) (June 2, 2025)
ANI Pharmaceuticals Inc. (PDF) (June 2, 2025)
May
Khursheed Haider, M.D.; Decision and Order (PDF) (May 22, 2025)
Quagen Pharmaceuticals LLC (PDF) (May 20, 2025)
Patheon API Inc. (PDF) (May 20, 2025)
Usona Institute (PDF) (May 20, 2025)
Wedgewood Pharmacy LLC (PDF) (May 14, 2025)
Research Triangle Institute (PDF) (May 14, 2025)
Pall Life Sciences PR, LLC (PDF) (May 14, 2025)
Edmund Ayoub Jr., M.D.; Decision and Order (PDF) (May 7, 2025)
Margaret Dennis, D.M.D.; Default Decision and Order (PDF) (May 7, 2025)
Peter Dashkoff, M.D.; Decision and Order (PDF) (May 7, 2025)
Mohan Kaza, M.D.; Default Decision and Order (PDF) (May 7, 2025)
Unither Manufacturing LLC (PDF) (May 1, 2025)
United States Pharmacopeial Convention (PDF) (May 1, 2025)
April
Skalar Pharma LLC (PDF) (April 28, 2025)
Lipomed (PDF) (April 28, 2025)
Pisgah Laboratories Inc. (PDF) (April 28, 2025)
Almac Clinical Services Inc. (ASCI) (PDF) (April 28, 2025)
VHG Labs DBA LGC Standards (PDF) (April 28, 2025)
Pharmaron Manufacturing Services (US), LLC; Correction (PDF) (April 28, 2025)
Siemens Healthcare Diagnostics Inc. (PDF) (April 28, 2025)
Liberty Pharmacy Inc.; Metro Care Pharmacy Inc.; Ritecare Pharmacy Inc.; United Pharmacy Upper Darby Inc.; Decision and Order (PDF) (April 25, 2025)
Syed Warsi, M.D.; Decision and Order (PDF) (April 25, 2025)
Royal Emerald Pharmaceuticals (PDF) (April 25, 2025)
SpecGx LLC (PDF) (April 25, 2025)
De Novo Services, LLC; Decision and Order (PDF) (April 23, 2025)
Svetlana Burtman, N.P.; Decision and Order (PDF) (April 22, 2025)
John Stanton, M.D.; Decision and Order (PDF) (April 21, 2025)
Scottsdale Research Institute (PDF) (April 18, 2025)
Patheon API Services Inc. (PDF) (April 18, 2025)
Myonex LLC (PDF) (April 18, 2025)
Stepan Company (PDF) (April 18, 2025)
Research Triangle Institute (PDF) (April 18, 2025)
Restek Corporation (PDF) (April 18, 2025)
Henry-Norbert O. Ndekwe, M.D.; Decision and Order (PDF) (April 16, 2025)
Moustafa M. Aboshady, M.D.; Decision and Order (PDF) (April 16, 2025)
Empire Pharmacy Inc.; Skyline Pharmacy Inc.; Decision and Order (PDF) (April 16, 2025)
Ajumobi Agu, M.D.; Decision and Order (PDF) (April 16, 2025)
Lona Bibbs-Walker, D.D.S.; Decision and Order (PDF) (April 16, 2025)
Victor Augusto Silva, M.D.; Order (PDF) (April 16, 2025)
David Israel, M.D.; Decision and Order (PDF) (April 16, 2025)
Phong H. Tran, M.D.; Decision and Order (PDF) (April 14, 2025)
Eagle Pharmacy; Decision and Order (PDF) (April 14, 2025)
Mariste Pharmacy; Decision and Order (PDF) (April 14, 2025)
Prescript Pharmaceuticals; Decision and Order (PDF) (April 2, 2025)
Jennifer Marie Lager-Fermon, D.O.; Decision and Order (PDF) (April 2, 2025)
Phong H. Tran, M.D.; Decision and Order (PDF) (April 1, 2025)
Baijes Bissonnet Pharmacy; Decision and Order (PDF) (April 1, 2025)
Mary Massullo, D.O.; Decision and Order (PDF) (April 1, 2025)
March
Willard J. Davis, D.O.; Decision And Order (PDF) (March 27, 2025)
Joely Keen, A.P.R.N.; Decision and Order (PDF) (March 27, 2025)
Harvey Leslie, M.D.; Decision and Order (PDF) (March 27, 2025)
Thomas Andr’e Endicott, D.D.S.; Decision and Order (PDF) (March 27, 2025)
Promega Corporation (PDF) (March 27, 2025)
Baxter Research Lab (PDF) (March 27, 2025)
Patheon API Services, Inc. (PDF) (March 27, 2025)
Ohana Bio Pharma, LLC (PDF) (March 27, 2025)
Royal Beverages, LLC (PDF) (March 27, 2025)
Restek Corporation (PDF) (March 27, 2025)
Royal Emerald Pharmaceuticals (PDF) (March 27, 2025)
SpecGx LLC (PDF) (March 27, 2025)
Pharmaron Manufacturing Services (US) LLC (PDF) (March 26, 2025)
Pharmaron Manufacturing Services (US), LLC (PDF) (March 26, 2025)
Sterling Wisconsin, LLC (PDF) (March 26, 2025)
Maridose LLC (I) (PDF) (March 26, 2025)
SpecGx LLC (PDF) (March 26, 2025)
Final Rule: Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients (PDF) (March 24, 2025)
Linwood A. Starks, D.V.M.; Decision and Order (PDF) (March 20, 2025)
Rachel Jackson, P.A.; Decision and Order (PDF) (March 20, 2025)
William Needham, N.P.; Decision and Order (PDF) (March 20, 2025)
Margaret Sprague, M.D.; Decision and Order (PDF) (March 20, 2025)
Hazem Barmada, M.D.; Decision and Order (PDF) (March 20, 2025)
Sterling Pharma USA LLC (PDF) (March 17, 2025)
Fisher Clinical Services, Inc. (PDF) (March 17, 2025)
Meridian Medical Technologies, LLC (PDF) (March 13, 2025)
Patheon Pharmaceuticals Inc. (PDF) (March 13, 2025)
Fisher Clinical Services, Inc. (PDF) (March 13, 2025)
Sigma Aldrich Research Biochemicals Inc. (PDF) (March 13, 2025)
Stepan Company (PDF) (March 10, 2025)
LTS Therapy Systems, LLC (PDF) (March 7, 2025)
Indivior Inc. (PDF) (March 6, 2025)
Aphena Pharma Solutions MD, LLC (PDF) (March 6, 2025)
February
Safe Online Pharmacies (February 28, 2025)
How do I know if a medication I purchased online is safe?
Groff NA Hemplex LLC (PDF) (February 27, 2025)
Sharp Clinical Services, LLC (PDF) (February 26, 2025)
Catalent Pharma Solutions, LLC (PDF) (February 26, 2025)
S&B Pharma LLC DBA Norac Pharma (PDF) (February 26, 2025)
Jason Weakley R.N., A.P.R.N.; Decision and Order (PDF) (February 21, 2025)
Final Rule: Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients (PDF) (February 19, 2025)
Scottsdale Research Institute (PDF) (February 18, 2025)
Scottsdale Research Institute (PDF) (February 18, 2025)
Mylan Pharmaceuticals, Inc. (PDF) (February 18, 2025)
Patheon API Inc. (PDF) (February 18, 2025)
Janssen Pharmaceuticals, Inc. (PDF) (February 18, 2025)
Purisys, LLC (PDF) (February 18, 2025)
Lonza Tampa, LLC (PDF) (February 18, 2025)
Robert L. Carter, D.D.S.; Decision and Order (PDF) (February 14, 2025)
Yogesh Patel, M.D.; Decision and Order (PDF) (February 14, 2025)
Benuvia Operations, LLC (PDF) (February 13, 2025)
Veranova, L.P. (PDF) (February 13, 2025)
Purisys, LLC (PDF) (February 13, 2025)
University of Kentucky Cannabis Center (PDF) (February 13, 2025)
Maridose LLC (PDF) (February 13, 2025)
Mylan Inc. (PDF) (February 13, 2025)
Janssen Pharmaceuticals Inc. (PDF) (February 13, 2025)
David Bockoff, M.D.; Decision and Order (PDF) (February 10, 2025)
Massoud Amini, M.D.; Decision and Order (PDF) (February 7, 2025)
Herold Pierre-Louis, P.A.; Decision and Order (PDF) (February 7, 2025)
James T. Craig, D.D.S.; Decision and Order (PDF) (February 7, 2025)
January 2025
Organic Consultants LLC DBA Cascade Chemistry (PDF) (January 31, 2025)
Medi-Physics Inc. DBA GE Healthcare (PDF) (January 31, 2025)
Catalent Greenville, Inc. (PDF) (January 31, 2025)
30-Day Notice: Recordkeeping for Electronic Prescriptions for Controlled Substances (PDF) (January 30, 2025)
Vici Health Sciences, LLC (PDF) (January 28, 2025)
Aveva Drug Delivery Systems, Inc. (PDF) (January 28, 2025)
Noramco (PDF) (January 24, 2025)
VHG Labs DBA LGC Standards (PDF) (January 24, 2025)
Veranova, L.P. (PDF) (January 24, 2025)
Xubex Community Pharmacy; Decision and Order (PDF) (January 23, 2025)
Neumann's Pharmacy, LLC; Decision and Order (PDF) (January 23, 2025)
Groff Health, Inc. (PDF) (January 21, 2025)
Siegfried USA, LLC (PDF) (January 21, 2025)
Invizyne Technologies, Inc. (PDF) (January 21, 2025)
Final Rule: Continuity of Care via Telemedicine for Veterans Affairs Patients (PDF) (January 17, 2025)
Final Rule: Expansion of Buprenorphine Treatment via Telemedicine Encounter (PDF) (January 17, 2025)
Proposed Rule: Special Registrations for Telemedicine and Limited State Telemedicine Registrations (PDF) (January 17, 2025)
Laura M. Bellew, N.P.; Decision and Order (PDF) (January 17, 2025)
Kim Routh, D.O.; Decision and Order (PDF) (January 10, 2025)
December
Temporary Rule: Extension of Temporary Placement of Seven Specific Fentanyl-Related Substances in Schedule I of the Controlled Substances Act (PDF) (December 30, 2024)
Proposed Rule: Placement of 4-Chloromethcathinone in Schedule I (PDF) (December 30, 2024)
Proposed Rule: Placement of Seven Specific Fentanyl-Related Substances in Schedule I (PDF) (December 30, 2024)
Soroosh Armandi, D.O.; Decision and Order (PDF) (December 30, 2024)
Maria Dewitt, N.P.; Decision and Order (PDF) (December 30, 2024)
Robert Esser, D.D.S.; Decision and Order (PDF) (December 30, 2024)
Matthew Okeke, M.D.; Decision and Order (PDF) (December 30, 2024)
Kevin Petersen, M.D.; Decision and Order (PDF) (December 30, 2024)
Jason Lee Ray, PA-C; Decision and Order (PDF) (December 30, 2024)
Shiva Akula, M.D.; Decision and Order (PDF) (December 30, 2024)
Samreen Riaz, D.D.S.; Decision and Order (PDF) (December 30, 2024)
Jeffrey W. Young, Jr., N.P.; Decision and Order (PDF) (December 30, 2024)
Irvine Labs Inc. (PDF) (December 30, 2024)
Siegfried USA, LLC (PDF) (December 30, 2024)
Curia New York, Inc. (PDF) (December 30, 2024)
Leading Pharma LLC (PDF) (December 18, 2024)
National Center for Natural Products Research (PDF) (December 13, 2024)
Groff NA Hemplex LLC (PDF) (December 13, 2024)
30-Day Notice: Application for Registration and Application for Registration Renewal; DEA Forms 224, 224A (PDF) (December 12, 2024)
Kinetochem LLC (PDF) (December 6, 2024)
Navinta LLC (PDF) (December 6, 2024)
Organic Standards Solutions International, LLC (PDF) (December 6, 2024)
Noramco (PDF) (December 6, 2024)
Curia Wisconsin, Inc. (PDF) (November 29, 2024)
Cambrex Charles City (PDF) (November 29, 2024)
- REGISTRATION
- REPORTING
- RESOURCES
- CONTACT US
- PRIVACY NOTICE
- GET EMAIL UPDATES
Get Email Updates
The United States Department of Justice
You are now leaving a Department of Justice Web site.
You are about to access:
The Department of Justice does not endorse the organizations or views represented by this site and takes no responsibility for, and exercises no control over, the accuracy, accessibility, copyright or trademark compliance or legality of the material contained on this site.
Thank you for visiting our site.